Background: The present study aimed to determine the effect of lentil sprouts [LS] on lipid profiles in overweight and obese patients with type 2 diabetes. Methods: Forty-eight overweight and obese type 2 diabetic patients, September and November2013, 30-65 years, participated in this clinical trial and randomly divided into two groups; LS group and controls. Patients in control group received conventional drug therapy, while patients in LS group received 60 g LS daily during 8 weeks along with routine medication. Significant differences among and between the groups were determined by independent t-test and paired sample t-test using SPSS software. The patients were blinded for the treatment. In this trial the effect of LS on serum lipid profiles were investigated. Results: Thirty-nine patients completed the study. After 8 weeks, serum levels of HDL-C was higher in the LS group compared to control group (48.3 ±1.9 vs. 42.8±1.7, P<0.03). TG and ox-LDL were lower in the LS group compared to controls [(127±13.4 vs. 170± 12.4 
Introduction
Type 2 diabetes is a metabolic disorder characterized by absolute or relative insulin deficiency, hyperglycemia, and disorder in carbohydrate as well as lipid metabolism.
1 "The development of chronic hyperglycemia in diabetes leads to severe damage in bodily tissues, organ dysfunctions and finally the irreversible failure of some critical organs of the body, especially eyes, kidneys, nerves and cardiovascular system". 2 Due to side effects of drugs used to treat diabetes, using complementary therapies and modification of the dietary pattern are good ways to improve the condition of disease. Legumes consumption has many effects in health improving, control and protection against metabolic diseases such as type 2 diabetes and cardiovascular diseases (CVD s ). 3 According to food ingredient table data, the amount of lentil seed fiber is 3.7 gr/100 and has a low glycemic index (21.1). After germination of seeds the amount of fiber and protein are increased. 4 After consumption of lentils in diabetic patients TC and glucose decreasedsignificantly 5 , and after consumption of lentil sprouts (LS) glucose decreased. 6 Besides, oxidized low density lipoprotein [ox-LDL] has a major role at the beginning and the development of atherosclerosis. 7 HDL-C has a major role in inhibiting LDL-C oxidation particles. 8 There are limited data regarding the potential properties of lentil sprouts on metabolic disorders; we therefore conducted this trial to investigate the effect of LS on serum TG, TC, LDL-C, HDL-C levels and atherogenic lipid parameters including AIP (atherogenic index of plasma), the ratios of ox-LDL/TC, ox-LDL/HDL-C and ox-LDL/LDL-C, TG/HDL and LDL/HDL were measured in overweight and obese patients with type 2 diabetes.
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Materials and Methods
Study population
Patients [male and female] with type 2 diabetes, referred to the Iran Diabetes Society and Endocrine Clinic of Taleghani Medical Center, Tehran, Iran were recruited for this study. Diagnosis of type 2 diabetes was according to American Diabetes Association. 9 This trial was conducted between September and November 2013. The patients aged 30-65yr, with body mass index ranged 25-40 kg/m 2 were included. Subjects with renal, hepatic disorders, gestation or lactation and patients who used insulin injection, contraceptive pills, glucocorticoid drugs or LS and multivitamin as well as supplements with antioxidant in the last 3 months were excluded from the study. Finally, forty-eight subjects [31 men and 17 women] were included and divided into two groups, LS=19 and control=20, randomly.
Intervention
Lentil sprouts preparation
The lentil seeds were placed in water for 30 hours. The seeds were placed on a wet cotton tissue. After 24 hours, lentil sprouts were packed and sent to patients. In these stages, temperature of environment was 25-30°C, but after the preparation, they were kept in a refrigerator.
Treatment
Patients in LS group received 60 g LS daily, and the patients in control group continued regular diet. Patients in the LS group consumed LS alone or with salads fresh. According to Dietary Reference Intake, each patient consumed 60 g LS in LS group. 10 In order to assess dietary changes during the study period three-day dietary recalls, including 2 weekends and 1 weekend day, was collected at baseline and again after 8 weeks from the subjects. Subjects provided with written informed consent. The method of consumption was written for the participants. They were asked to maintain their habitual life style, physical activity and dietary pattern during the eight weeks of study. Patients were excluded from the analysis if they consumed <85% of the packets 11 or changed their medication or reported severe side effects. For being confident that the patients consume LS, the researcher called them weekly.
Anthropometric and biochemical measurements
Anthropometric measurements including weight, height and waist circumference were measured at baseline and eight weeks later. Weight was measured with digital scale (Seca 707, Hamburg, Germany, nearest to 100g) while the subjects were minimally clothed without shoes. Height was measured to the nearest0.5 cm, in a standing position without shoes, using a tape meter. Body mass index [BMI] was calculated as follows: weight/ square of height [kg/m 2 ]. Venous blood samples were drawn after an overnight fasting at baseline and again after intervention [Days 0 and 56] and were centrifuged at 4°C and 500 g for 10 min to separate plasma. Venous blood sample volume was 7 ml. Serum concentrations of TC, triglyceride [TG] and HDL-C were evaluated by using the standard enzymatic methods with commercially available Parsazmun kits (Tehran, Iran). LDL-C was calculated from serum TC, TG and HDL-C according to the friedewalde equation. 12 TC was assayed with the cholesterol esterase and cholesterol oxidize method and TG was assayed by using glycerol phosphate oxidize. The monoclonal antibody was used by ELISA kit to qualify the concentration of serum oxidized LDL (Mercodia Company, Uppsala, Sweden). AIP as defined logarithm of the TG/HDL-C ratio, directly related to lipoprotein particle size and the risk of atherosclerosis [AS]. 13, 14 Inter-Intra-assay coefficient of variations of all assays were <5%.
Statistical analysis
According to statistical methods for triglyceride variable 15 with 95% confidence and 80% power, the sample size with regard to possible loss of the samples was calculated 20 patients in each group. The experimental data were analyzed by SPSS software, version16 (SPSS Inc., Chicago, IL, USA). The normality of the distribution of variables was determined by the Kolmogorov-Smirnov test. Analysis of covariance was used to identify any differences between two groups after intervention, adjusted for baseline measurements and covariates including lipid lowering and anti-diabetic drugs. The changes in anthropometric measurements, lipid profile and ox-LDL parameters of the participants between the beginning and end of the trial were compared by paired sample t-tests. The percent change for each variable was also calculated by formula [(8-weeks values-baseline values)/baseline values×100]. Also, P-value <0.05 was considered significant. Main researcher generated the random, enrolled participants and assigned participants to interventions.
Ethical approval
Ethics approval was obtained from Ethical Committee of Tabriz University of Medical Science. The trial has been registered in the Iranian Registry of Clinical trial at http://www.irct.ir with the following identification IRCT201305251640N9.
Results
Forty-eight subjects were enrolled and divided into two groups randomly, but only 39 were available for data analysis because some of them could not complete the entire protocol or come for secondary evaluation. Final analysis was per protocol. Randomization of the patients was simply enveloped. Patients were blinded. These 39 patients were composed of 12 women and 27 men ( Figure  1 ). Subjects' demographics are shown in Table 1 . No significant differences between groups were seen for mean age, duration of diabetes, weight, body mass index, blood lowering pressure drugs; nor were there any significant differences between the pretreatment serum values of total cholesterol, low density LDL-C, high density lipoprotein cholesterol [HDL-C], triglycerides, atherogenic index of plasma [AIP], TC/HDL-C ratio, LDL-C/HDL-C ratio, ox-LDL, ox-LDL/LDL-C ratio, ox-LDL/HDL-C ratio and ox-LDL/TC ratio in the 2 groups at baseline (Table2). Some patients used glucose lowering drugs including metformin and glibenclamide. Some participants used lipid-lowering drugs such as statins. Some of them used blood pressure lowering pressure such as nifdidin. Attention to disease severity differed amount of drugs for each patient. There were significant differences in lipid lowering and anti-diabetic drugs between two groups, therefore these variables were adjusted in the analysis. The mean dietary intakes of participants at baseline and after 8-week of intervention a presented in Table 3 .
There was no significant difference between the groups in total energy and nutrient intakes, as estimated by 3-day dietary recalls. Eight-week biochemical values of participants in the two groups, and the treatment effects of LS on lipid profiles are presented in Figure 2 . Data of this study were primary. In the LS group, the levels of HDL-C and LDL-C increased compared with baseline (P<0.03, P<0.06) but in the control group no significant change was seen. In the LS group the levels of TG, AIP and ox-LDL decreased compared with the baseline values (P<0.01 and P<0.07 and<0.6). Patients in the intervention group did not report any side-effects from LS consumption.
Fig. 2:
Mean differences of variables compared with baseline values in two groups (*significant difference within the groups using paired t-test, P<0.05).TC, total cholesterol; TG, triglyceride; LDL-C, low density lipoprotein; HDL-C, high density lipoprotein; ox-LDL, oxidized-low density lipoprotein; AIP, atherogenic index of plasma
Discussion
In this trial, we investigated the effect of LS on lipid profiles in overweight and obese patients with type 2 diabetes. TG and ox-LDL decreased (P<0.01 and P<0.6) and HDL-C increased (P<0.03) in LS group compared to control group.
Lipid blood disorders play a major role in CVD s risk in diabetic patients. 16 In an animal experiment, rats consumed whole cooked lentils, level of HDL-C was significantly increased. 17 Low HDL-C is an independent cardiovascular risk factor and management of HDL-C may contribute to the optimization of cardiovascular risk in Type 2 diabetes. 18 Changes in dietary pattern, physical activity and weight can convert HDL-C level. 19 In this study, patients were asked not to change their dietary pattern and physical activity. Weight of patients did not differ significantly between 2 groups after 8 weeks intervention. In a study, a high-fiber diet improved glycemic control and reduced serum lipids and HDL-C level increased in LS group after 8 weeks of LS consumption and this effect could be due to some bioactive components in LS. 20 Lentil seeds are rich source of fiber and micronutrients. Picillium increased the level of serum HDL-C in patients with type 2 diabetes. 21 Hypertriglyceridemia is a common form of dyslipidemia frequently associated with coronary heart disease (CHD). 22 Our results showed that TG level decreased in LS group after 8 weeks of LS consumption (P<0.01).Several mechanisms could explain favorable effects of lentil and lentil sprouts on lipid and lipoprotein metabolism; high content of fiber could decrease bile acid and cholesterol reabsorption from Ileum. 23 Another important finding of the current study was decreased TG/HDL-C ratio following treatment with LS. Decreased TG /HDL ratio is related to large and non-atherogen LDL-C particles. 24, 25 Diet rich in fruits and vegetables due to plant fibers, carotenoids, anti-oxidants and phytosterols can prevent and control non-communicable diseases such as diabetes. 26 Herbal antioxidants have insulin-like effects and increased glucose absorption in peripheral tissues. 27 Lentil seeds are rich source of antioxidants as compared to other cereals and have high antioxidant capacity. 28 Lentils had a higher oxygen radical absorbing capacity (ORCA)value than most of the common fruits and vegetables such as apples, plums, blackberries, cherries, figs, peaches, pears, orangs, garlic, cabbage and almonds. 29 Nutrient composition of lentil is shown in Table 4 . Low HDL-c and high TG concentration is considered as a main risk factor for development of, CHD. [31] [32] [33] Plasma ox-LDL increases in conditions such as diabetes, 34 central obesity 35 and CAD. This may be considered as a marker of the AS. 36 High level of ox-LDL may indicate the severity of pathological inflammatory response. 37, 38 Oxidation ratio of LDL had a stronger correlation with CVD s in comparison with plasma oxidized LDL. 39 ox-LDL and oxidation ratio of LDL (ox-LDL/TC, ox-LDL/HDL-C and ox-LDL/LDL-C) were closely related with AS, 39 and these indicators were better biomarkers for discriminating between patients with CVD s and healthy subjects than the usual tests. 39 ox-LDL/TC, ox-LDL/LDL-C, ox-LDL/HDL-C were higher in CVD s group. 40 Reduction of ox-LDL/LDL, ox-LDL/TC and ox-LDL/HDL-c could be related with key bioactive components in the LS.
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The present study had a few limitations because the sample size was small and the study duration was 8 weeks. Further studies with longer duration and various doses may shed more light on importance of the therapeutic effects of LS in diabetic patients. Due to some inclusion and exclusion criteria such as specified BMI range defined for this study, our findings could not be generalized and interpreted to all type 2 diabetic patients.
Conclusion
Consumption of LS as supplementary treatment in type 2 diabetes could have favorable effects on lipid metabolism and atherogenic lipid parameters. Such findings imply that nutritional intervention and use of functional foods such as lentil sprouts along with common medical treatment may be an important strategy in management of cardiovascular risk factors and metabolic disorders in type 2 diabetic patients.
